A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...

Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...

Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey towards seeing this treatment in the clinic. For this first phase, the aim ...

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

RADNOR, PA / ACCESS Newswire / February 21, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a ...

Arcus Biosciences, Inc. (NYSE: RCUS) announced on February 18, 2025, that it has entered into an underwriting agreement with Goldman Sachs & Co. LLC and Leerink Partners LLC for the offering, issuance ...

The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...

by Melbourne Storm 10 1:30 pm Go Media Stadium Sat ... Brisbane won their opening match of the trials 46-20 against the Cowboys before a second-string side beat Manly 20-14 the following week ...

Destiny 2’s pinnacle PVP activity, Trials of Osiris, returns yet again. If you want to know what this week’s featured map and weapon are, we have all that and more in this breakdown of the ...